PRPH Projected Dividend Yield

ProPhase Labs Inc ( NASDAQ : PRPH )

ProPhase Labs, Inc. is a biopharma, genomics, and diagnostics company. Co. provides whole genome sequencing solutions, while developing potential diagnostics and therapeutics in the fight against cancer. This includes a potentially life-saving cancer test focused on early detection of esophageal cancer and potential breakthrough cancer therapeutics with novel mechanisms of action. Its segments include diagnostic services and consumer products. The diagnostic services segment provides COVID-19 diagnostic information services to a broad range of customers in the U.S., including health plans, third party payers and government organizations.

17 YEAR PERFORMANCE RESULTS

PRPH Dividend History Detail
PRPH Dividend News
PRPH Competitors News
# of Shares: 0 Closing Price: 0.29 Current Market Value: 0.00 Cost Basis: 0.00 Date Acquired:
Dividend Cash Flow
Year Annual Dividend Dividend Growth # of Shares Annual Dividend Income Yield On Cost %
2018 1.00 0% 0 $ 0.00 0.00%
2019 0.50 0% 0 $ 0.00 0.00%
2020 0.00 0% 0 $ 0.00 0.00%
2021 0.30 0% 0 $ 0.00 0.00%
2023 0.00 0% 0 $ 0.00 0.00%
2024 0.00 0% 0 $ 0.00 0.00%
2025 0.00 0% 0 $ 0.00 0.00%
2026 0.00 0% 0 $ 0.00 0.00%
Using the current years Dividend Growth rate of 0% and projecting 0% forward the annual dividend income in 10/yrs would be $ 0.00 with a yield on cost % of 0.00%
Rolling Last 4 qtrs dividends total $ 0.00 and Previous last 4 qtrs dividends total $ 0.00
Dividend 1 Yr Growth = ( 0.00 – 0.00 ) × 100 = 0% (Click the Edit pencil if you want to modify the forward dividend growth rate projection)
0.00
Year
Declaration Date
Ex-Dividend Date
Record Date
Payable Date
Dividend $ Amount
2022
May 13, 2022
May 24, 2022
May 25, 2022
Jun 03, 2022
0.3000
2022
Feb 16, 2022
Feb 28, 2022
Mar 01, 2022
Mar 10, 2022
0.3000
2022 Total:
0.6000
2021
May 13, 2021
May 24, 2021
May 25, 2021
Jun 03, 2021
0.3000
2021 Total:
0.3000
X
Search Dividend Investor